Senior Director, Commercialization and Intrapreneurship
- PhD, Analytical Chemistry, University of North Carolina at Chapel Hill
- BS, Chemistry, Furman University
Ginger Rothrock, PhD, leads a cross-RTI team managing the institute’s commercialization portfolio, a role in which she vets RTI technologies for commercial impact and builds teams to accomplish early-stage market assessments and determine business models. She has led multimillion dollar research efforts in emerging fields to develop new products and capabilities for her corporate partners. Dr. Rothrock also works with regional and global biomedical technology accelerators to employ consistent approaches and best practices to translate and de-risk product concepts to meet the specific needs of stakeholders.
She is an expert in the business and technical development of emerging technologies. Her specializations include product development, advanced materials, biomedical innovation, commercialization, and market intelligence.
Prior to joining RTI, Dr. Rothrock was co-founder and principal technologist of Liquidia Technologies, a dynamic mid-stage nanobiotech firm. At Liquidia, she served as the project and technical manager for multiple product feasibility studies in the areas of nanotechnology-focused cleantech and life science applications.
In addition to her technical and business contributions, Dr. Rothrock is active in Women in STEM organizations and is extremely passionate about mentoring women and students in science, technology, engineering, and mathematics fields. In 2015, she was named to the Triangle Business Journal’s 40 Under 40 list, which highlights successful up-and-coming professionals.